Komori
Share Issuance and Disposal6678Techno Medica Co.,Ltd.Electrical Equipment and Precision Instruments

Notice Regarding the Disposal of Treasury Shares as Stock-Based Compensation

The Company resolved to dispose of 19,800 treasury shares at ¥1,968 per share to 4 directors as restricted stock compensation. The shares may not be transferred for a specified period, including while the recipients remain in office.

Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
19800
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Disposal of treasury shares as share-based compensation (restricted stock compensation)

Who receives how much19,800Shares

19,800 shares of the Company's common stock (treasury shares)

4 directors (excluding directors who are Audit and Supervisory Committee members and outside directors)19,800 shares

The lower thin line represents the existing number of shares to which these shares will be added.

¥1,968 per share
Total issue value

¥38,966,400

Amount of funds to be raised
Total amount paid in: ¥38,966,400; estimated net proceeds: Not disclosed
Total Stock-Based Compensation
Total monetary compensation receivables: ¥38,966,400 (within the annual limit of ¥50 million under the plan)
Conditions on transfer restrictions

Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.

Transfer restriction period
From 24 July 2026 until the date on which the recipient ceases to hold any position as a director or executive officer of the Company or any of its subsidiaries
Conditions for lifting transfer restrictions
Provided that the recipient continuously holds a position as a director or executive officer of the Company or any of its subsidiaries from 24 July 2026 through 1 July 2027, all transfer restrictions on the allotted shares will be released upon expiration of the transfer restriction period. If the recipient ceases to hold office due to death, expiration of the term of office or any other reason deemed legitimate by the Company's Board of Directors, transfer restrictions will be released on a pro rata basis according to the number of months in office.
Reason for acquisition without consideration
At the expiration of the transfer restriction period, the Company will automatically acquire without consideration any of the allocated shares for which the transfer restrictions have not been released.
Categories and Number of Persons Covered
4 directors (excluding directors who are Audit and Supervisory Committee members and outside directors) · 19,800 shares
Intended allottee's holding policy
The shares may not be transferred, pledged or otherwise disposed of from 24 July 2026 until the date on which the recipient ceases to hold any position as a director or executive officer of the Company or any of its subsidiaries.
Payment date
24 July 2026
Basis for determining the amount to be paid
The closing price of the Company's common stock on the Tokyo Stock Exchange on 30 June 2026, the business day preceding the date of the Board of Directors' resolution, was ¥1,968. No discount or premium was stated.
Details of issuance or disposal
ItemDetails
Type of issuance or disposalDisposal of treasury shares as share-based compensation (restricted stock compensation)
Number of shares to be issued or disposed of19,800 shares of the Company's common stock (treasury shares)
Issue price and disposal price¥1,968 per share
Total issue value¥38,966,400
Amount of funds to be raisedTotal amount paid in: ¥38,966,400; estimated net proceeds: Not disclosed
Payment date24 July 2026
Intended allotteeName 4 directors (excluding directors who are Audit and Supervisory Committee members and outside directors) / Number of Shares 19,800 shares
Intended allottee's holding policyThe shares may not be transferred, pledged or otherwise disposed of from 24 July 2026 until the date on which the recipient ceases to hold any position as a director or executive officer of the Company or any of its subsidiaries.
Basis for determining the amount to be paidThe closing price of the Company's common stock on the Tokyo Stock Exchange on 30 June 2026, the business day preceding the date of the Board of Directors' resolution, was ¥1,968. No discount or premium was stated.
Transfer restriction periodFrom 24 July 2026 until the date on which the recipient ceases to hold any position as a director or executive officer of the Company or any of its subsidiaries
Conditions for lifting transfer restrictionsProvided that the recipient continuously holds a position as a director or executive officer of the Company or any of its subsidiaries from 24 July 2026 through 1 July 2027, all transfer restrictions on the allotted shares will be released upon expiration of the transfer restriction period. If the recipient ceases to hold office due to death, expiration of the term of office or any other reason deemed legitimate by the Company's Board of Directors, transfer restrictions will be released on a pro rata basis according to the number of months in office.
Reason for acquisition without considerationAt the expiration of the transfer restriction period, the Company will automatically acquire without consideration any of the allocated shares for which the transfer restrictions have not been released.
Categories and Number of Persons Covered4 directors (excluding directors who are Audit and Supervisory Committee members and outside directors) · 19,800 shares
Total Stock-Based CompensationTotal monetary compensation receivables: ¥38,966,400 (within the annual limit of ¥50 million under the plan)
Items this document does not state (14)
Estimated issuance expensesSpecific use of fundsDilution RateTotal number of issued sharesExercise priceExercise periodNumber of Stock Acquisition RightsUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To provide directors with ongoing incentives to increase shareholder value during their terms of office, and to promote sustained improvement in corporate value over the medium to long term and value sharing with shareholders.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Disposal of Treasury Shares as Stock-Based Compensation | Techno Medica Co.,Ltd. (6678) timely disclosure | Komori